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Abstract  
Objective: Obsessive-Compulsive Disorder (OCD) is associated with a variable risk of suicide but 
its prevalence and risk factors have not been extensively investigated. The present study was aimed 
to assess prevalence of suicide attempt (SA) and associated socio-demographic and clinical features 
in a large international sample of OCD patients. 
Methods: 425 OCD outpatients, recruited by the “international college of obsessive-compulsive 
spectrum disorders” (ICOCS) network, were assessed and categorized in groups with or without 
lifetime SA and their socio-demographic and clinical variables compared through Pearson Chi-
squared and t tests. Logistic regression was performed to assess the impact of collected data on the 
SA variable. 
Results: 14.6% of the sample reported at least one lifetime SA. Patients with SA had significantly 
higher rates of comorbid psychiatric (60%vs17%, p<.001) and medical disorders (51%vs15%, 
p<.001) as well as previous hospitalizations (62%vs11%, p<.001), compared with patients with no 
SA. With respect to geographical differences, European and South African patients showed 
significantly higher rates of SA (40% and 39%, respectively) compared to North American and 
Middle-Eastern individuals (13% and 8%, respectively) (χ2=11.4, p<.001). Logistic regression did 
not show any statistically significant predictor of SA among selected independent variables. 
Conclusions: The present international multicenter study found a lifetime SA prevalence of 
approximately 15% in OCD patients, with higher rates of psychiatric and medical comorbidities and 
previous hospitalizations in patients with previous SA. Along with potential geographical 
influences, the presence of the above-mentioned features should recommend additional caution in 
the assessment of suicide risk in OCD patients.  
Key words: Obsessive-compulsive disorder (OCD), suicide attempt (SA), prevalence, comorbidity, 
previous hospitalization. 
Introduction 
Obsessive-compulsive disorder (OCD) is a highly disabling condition, often characterized by a 
chronic course, high rates of comorbidity and treatment refractoriness (Grabe et al., 2006; 
Fontenelle et al., 2006). Recently, the 5th Edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5) has allocated OCD in a separate chapter (American Psychiatric 
Association, 2013), which confirms its autonomy from anxiety disorders and, in turn, its leading 
role for other related disorders.  
As for other disabling psychiatric disorders, suicidal behaviors represent the most severe and tragic 
evolution of OCD.  The prevalence and clinical correlates of suicidal behaviors in OCD have been 
previously investigated, revealing heterogeneous results. In fact, data about suicidal behaviors 
among OCD patients are quite mixed and there is growing evidence that they could represent an 
underestimated phenomenon (Kamath et al, 2007).  In this respect, a recent meta-analysis by 
Angelakis and colleagues reported an incidence of suicidality in OCD higher than in the general 
population, with a median rate of suicidal ideation and suicide attempt (SA) of 27.9% and 10.3%, 
respectively (Angelakis et al, 2015). Among factors accounting for variability in suicide rates, 
different geographical and cultural issues have been considered. Indirect evidence of genuine 
differences, within national suicide rates, emerged in studies from United States and Australia, 
which have shown significant rank correlations between the suicide rates of immigrants and those 
of their country of birth (Marusic, 2005; Burvill, 1998). 
Suicidality in OCD patients has been linked to several conditions, such as early age at onset, 
presence of medical and psychiatric comorbidities (particularly mood disorders) (Lochner et al, 
2014), generic risk factors for suicide (e.g., a positive history of SA or suicide ideation), emotional-
cognitive aspects (e.g., hopelessness), severity of symptoms (particularly concerning aggressive, 
symmetry/ordering and sexual/religious obsessions) and treatment resistance (Balci et al, 2010; 
Angelakis et al, 2015; Dhyani et al, 2013; Kamath et al, 2007; Gupta et al., 2014).  
Recently, an Italian study indicated alexithymia as a potential risk factor for increased suicidality in 
OCD patients (De Berardis et al., 2015). In fact, the inability to recognize and deal with emotions 
has shown a prevalence of 20%–40% in patients with OCD (De Berardis et al., 2005) and has been 
linked to increased severity of illness and lower insight (Carpenter and Chung, 2011), resulting in a 
higher suicide risk (De Berardis et al., 2008). A suicidal act may, therefore, be a way of expressing 
an intolerable psychological pain (Pompili, 2010). 
Recently, a link between serum lipid levels and suicidal ideation has been hypothesized, since some 
studies reported that serum lipid levels might be involved in neuropsychiatric disorders including 
OCD (Papkostas et al., 2004; De Berardis et al., 2014), this parameter being potentially identified as 
a biomarker of suicidality. 
In light of previous observations, an additional characterization of suicide risk and behaviors in 
OCD patients appears of relevant clinical interest to implement an effective treatment and 
comprehensive management of individuals at risk. Therefore, the aim of the present multicenter 
study was to assess the prevalence of suicide attempts and associated socio-demographic and 
clinical features in a large international sample of OCD patients. 
 
Methods  
Four hundred and twenty-five consecutive OCD outpatients of either gender and any age, attending 
different OCD clinics worldwide, participating to the “International College of Obsessive-
Compulsive Spectrum Disorders” (ICOCS) (Dell’Osso et al, 2016) network were recruited. This 
network includes several OCD academic and tertiary Clinics (Menchon et al., 2016) from across the 
globe – i.e., America (Canada, the United States and Mexico), Africa (Libia and South Africa), 
Europe (Spain, Italy, Turkey, Bulgaria, UK), and the Middle East (Israel).  
A written informed consent and a specific approval from local Ethics Committee/Institutional 
Review Board for using patients’ information for research purposes were obtained. Diagnoses were 
performed using the Structural Clinical Interview based on DSM-IV criteria (SCID-I and II) (First 
et al., 1997; First et al., 2002 A and B). Socio-demographic and clinical variables were collected 
through a clinical interview, then included in a common web-database. In particular, for the present 
study, the following variables were analyzed: age, gender, age of onset, presence of comorbid 
psychiatric disorders and poly-comorbidity (> 2 comorbid psychiatric disorders), medical 
comorbidity, OCD severity assessed with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) 
(Goodman et al., 1989), current pharmacological therapy and Cognitive Behavioral Treatment 
(CBT), lifetime psychiatric hospitalization and lifetime history of suicide attempt. OCD severity 
was also defined by means of a qualitative characterization, identifying a “high severity of illness” 
category, with a Y-BOCS score >24.  
Patients were categorized into two groups on the basis of a positive or negative history of SA and 
the aforementioned socio-demographic and clinical variables were compared between the two 
subgroups in order to identify any possible difference. 
Pearson Chi-squared tests for categorical variables and t-test for continuous variables were used to 
perform this comparison among subgroups.  
Furthermore, to assess potential confounders, binary logistic regressions were performed to 
investigate significant relationships between lifetime SA (dependent variable) and other variables 
(included as covariates). 
All the statistical analyses were performed using SPSS 22 for Windows IBM software, with p<.05 
as level of statistical significance. 
 
Results 
Socio-demographic and clinical variables of the sample are reported in Table 1. 
The sample was characterized by 58% (n=245) of females and 42% (n=180) of males, a mean age 
of 42.9±12.6 years and a mean age at onset of 19.2±9.9 years.  
Patients with a positive history of SA represented the 14.6% of the sample (n=62), showed a mean 
age at onset of 17.9±9.7 years and were represented for the 60% (n=37) by females.  
Patients with lifetime history of SA showed a series of significant differences compared to patients 
with no previous SA. Psychiatric comorbidity, was significantly more present in patients with 
lifetime history of SA compared to individuals without previous SA (60%vs17%, χ2=52.7, p<.001) 
(Figure 1). In particular, Tic Disorder (TD) was found to be significantly more represented than 
other psychiatric comorbidities (41.9%), followed by Major Depressive Disorder (MDD) (8.1%) 
and Tourette’s Syndrome (TS) (1.6%) (χ2=109.2, p<.001) in patients with a lifetime history of SA. 
In addition, patients with vs without previous SA showed a significantly higher rate of medical 
comorbidity (51%vs15%, χ2=42.4, p<.001) (Figure 1). Moreover, they showed a higher rate of 
previous psychiatric hospitalization (62%vs38%, χ2=90.03, p<.001) (Figure 1). 
No differences in terms of rates of presence/absence of current psychopharmacological treatment 
were found between patients with vs without previous SA, whereas patients with history of SA 
showed a higher rate of past/current CBT (66% vs 38%, χ2=16.2, p<.001).  
With respect to geographical differences of Clinics involved in the network, European and South 
African patients showed significantly higher rates of positive lifetime history of SA (40% and 39%, 
respectively) compared to subjects from North America and Middle-East (13% and 8%, 
respectively) (χ2=11.4, p<.001). 
In terms of OCD severity, no quantitative/qualitative differences in relation to Y-BOCS scores were 
found between patients with or without previous suicide attempts. 
No differences were found in terms of age at onset between patients with or without previous SA, 
nor in terms of pre-adult (<18 years) and adult ( 18 years) onset. 
Variables that were entered into binary logistic regression, in order to assess which features were 
best associated with lifetime SA, included: age of onset, gender, Y-BOCS scores, comorbid 
psychiatric disorders and lifetime hospitalization.   
Our model was valid (Hosmer & Lemeshow test: χ2=4.3, df=8, p=0.83), and binary logistic 
regression was significant overall (Omnibus test: χ2=112.33, df=12, p<0.001), predicting 90.5% of 
cases. However, none of the selected independent variables could show a unique statistically 
significant contribution to the model.  
 
Discussion 
To authors’ knowledge, this is the first and largest international multicenter study investigating 
prevalence and correlates of SA in OCD. In fact, most of the studies in the field are limited by 
sample size and restricted geographical catchment area, without multicenter comparisons. Patients 
with a positive lifetime history of SA represented the 14.6% of the whole sample, with a higher rate 
compared to what was recently reported by a recent meta-analysis by Angelakis and colleagues, 
observing median rates of SA of 10.3% (Angelakis et al, 2015). It has to be noticed that our SA rate 
is positioned in the middle of the range indicated by the available literature, with rates of SA 
between 3% to 27% in OCD patients (Hollander et al 1996, 1998; Torres et al., 2007, 2011; Alonso 
et al., 2010; Kamath et al., 2007). 
In the present study, significantly higher rates of lifetime history of SA were reported in OCD 
patients from Europe and South Africa (40% and 39%, respectively), compared to patients from 
North America and Middle-East (13% and 8%, respectively). Such differences might have been due 
to specific clinical features including higher severity of illness, presence of comorbidity, early onset 
and longer duration of illness but might also depend on cultural differences about implications of 
suicide and SAs for patients and their relatives (Goldsmith et al., 2002; Klonsky et al., 2016). The 
presence of geographical differences and, likely, cultural peculiarities in suicidal behaviors may 
explain the heterogeneity in the observed rated of SAs, reported by some recent and previous 
studies with OCD patients. 
In terms of comorbidity, the 23% of our sample showed lifetime psychiatric comorbid disorders, 
highlighting the important role played by this variable in OCD (Lochner C et al, 2014). Of note, the 
group with positive history of SA, showed the presence of comorbidity in a rate of four times higher 
compared with the group with no history of SAs. Among psychiatric comorbidities, TD was the 
most represented (41.9%), followed by MDD and TS (8.1% and 1.6%, respectively). In this respect, 
Viswanath and colleagues reported that OCD, when comorbid with MDD, was more severe and 
associated with higher suicidal risk (Viswanath et al., 2012). Moreover, MDD has been linked to 
the presence of hopelessness that, in turn, was found to be a strong predictor of suicidal ideation in 
OCD (Brezo et al., 2006). Nonetheless, TD represented the most frequently comorbid condition 
observed in patients with SA and, even though suicidal thoughts and behaviors have been poorly 
investigated in patients with TD, it is well established that OCD patients with comorbid TD have 
generally early onset, relevant disability and worse response to pharmaco-therapy (Rosario-Campos 
et al., 2001). Taken as a whole, the above-mentioned features may contribute to a  worse long-term 
outcome, including also a higher incidence of SAs. Of note, a recent multicenter American study 
investigating the frequency and clinical correlates of suicidal thoughts and behaviors in a sample of 
children and adolescents with chronic TD showed a significantly higher rate of suicidal thoughts 
and/or behaviors compared to community control sample (10% vs 3%). In addition, the study 
showed an association of suicidal attempts and behaviors with tic severity and severity of comorbid 
OCD, anxious-depressive symptoms and Attention-Deficit/Hyperactivity Disorder (Storch et al., 
2015). Increased tic symptom severity and related impairment may, in fact, contribute to heightened 
distress, resulting in an increased amount of suicidal thoughts and higher risk of suicidal behaviors, 
potentially expressed in an impulsive manner, when patients feel upset or distressed. Similarly, 
increased suicidal behavior in TS was described in patients presenting with moderate to severe tics, 
self-injurious behaviors, comorbid affective disorders, OCD and impulsive-aggressive behaviors 
(Davila et al., 2010). In light of the above, our results seem to confirm that specific comorbid 
conditions, in particular TD, MDD and TS, may increase the overall burden and disability of OCD 
patients, contributing to an increased rate of SA.  
Psychiatric poly-comorbidity did not show significant differences between the two groups, likely 
due to the presence of only few positive cases, even though the group with lifetime positive history 
of SA showed a rate that was twice higher compared to the other group (8%vs4%).   
Likewise, the significantly higher rate of medical comorbidities (51%) in patients with a positive 
history of SAs could be interpreted as an additional risk factor, further burdening the already 
relevant disability perceived by OCD patients. Data from literature emphasize the role of medical 
illness on suicidality and this relationship is often, but not always, explained by secondary 
depression (Sanna et al., 2014). Often, illness or physical pain may represent the trigger for suicide 
ideation in psychiatric patients (Lee et al., 2014). Nonetheless, this result has not been reported to 
date and to authors’ knowledge and it represents a quite original finding in OCD, requiring future 
confirm. 
Another noteworthy finding from the present study is represented by the lifetime psychiatric 
hospitalization rate. In fact, 18% of the whole sample showed at least one previous psychiatric 
hospitalization. This represents a higher rate compared to the 6.4% rate found by the National 
Comorbidity Survey study in the U.S. (Ruscio et al., 2008) and it may be related to the tertiary 
Clinic setting of the present study, likely reflecting a higher severity of illness of recruited patients. 
With respect to the subgroup of patients with a positive history of SA, a higher rate of previous 
psychiatric hospitalization (62%) was found compared to the other subgroup (11%). This result may 
be interpreted in several ways. First, hospitalization might be related to a globally more severe 
clinical picture, frequently involving both psychopathological and social aspects, as previously 
mentioned. Moreover, a specific influence of psychiatric comorbidities may, in turn, have 
contributed to hospitalization, especially in case of comorbid mood disorders. Ultimately, 
hospitalizations might have been the consequence of a SA. Actually, all these circumstances have 
already been described as possible causes of hospitalization in OCD patients (Brakoulias and Sara, 
2011). 
No differences between the subgroups were found in terms of current psychopharmacological 
treatment, while patients with a positive history of SA showed a higher rate of past/present CBT, 
compared to those without history no previous SA (66% vs 38%). CBT is considered among first-
line treatments in OCD and medications tend to be reserved for more severe cases and/or to young 
people, who fail to respond to psychotherapy (National Institute for Health and Clinical Excellence, 
2005; Geller and March, 2012). However, it could be speculated that patients with a long duration 
of illness and a worse psychosocial impairment needed CBT, as sole or integrated therapy, to obtain 
larger benefit (Albert et al., 2012; Dell’Osso et al, 2013). Moreover, it has to be underlined that, in 
the study sample, psychopharmacological treatments were more commonly used than CBT, this 
phenomenon potentially reflecting the overall severity of illness of the sample.  
In terms of severity of OCD, only non significantly higher qualitative and quantitative scores/rates 
were observed in patients with a lifetime history of SA, who might be considered as moderately 
severe, following Storch’ recent classification (Storch et al., 2015). This result seems to suggest that 
suicidality in OCD may be the consequence of many risk factors, with severity of illness not 
necessarily playing the leading role (Alonso et al., 2010). Nonetheless, the observed non 
significantly higher mean Y-BOCS scores and higher rates of severe OCD as well as the earlier 
onset of OCD and the higher rate of pre-adult onset in patients with positive history of SA seem to 
converge in identifying an overall more severe and precocious profile of illness in these subjects 
compared to individuals with no history of SA. In addition, severity of illness was measured 
through the Y-BOCS which, in spite of being the more widely used scale in clinical practice, may 
capture only some specific aspects of the overall severity of illness. 
The logistic regression did not find any specific predictor of SA amongst the main clinical and 
socio-demographic variables, suggesting that suicidality in OCD may likely be a multifactorial 
dimension, not recognizing single, major predicting factors. 
The findings reported in the present study should be interpreted in light of some limitations. First, 
the present study investigated the presence of at least one previous SA and did not explore the 
overall number of SAs, methods used to attempt suicide, lethality of attempts or the presence of 
suicidal ideation per se, which might provide a more comprehensive scenario of the suicidal 
dimension in OCD.  
The possible presence of recall bias should be taken into account, since some demographic data 
were retrospectively determined. In addition, it has to be noticed that Centers participating to the 
ICOCS network have well-established expertise in the field of diagnosis and treatment of OCD and 
it may be speculated that patients attending such services may have shown higher severity of illness 
and, therefore, do not necessary reflect the clinical conditions of patients usually observed 
elsewhere. Furthermore, the severity of illness was measured through the Y-BOCS with no 
instruments assessing disability and quality of life and potentially showing different results across 
different groups. Finally, reported data may only apply to patients seeking treatment, such 
population being not necessarily representative of the entire population of OCD patients.  
Further research is required to confirm the present epidemiologic results and to further explore the 
prevalence of SAs and clinical features of suicide attempters in OCD. 
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Tables and Figures 
 
Table 1. Socio-demographic and clinical variables of the total sample and subgroups divided on the 
basis of the presence of suicide attempt 
 
 
TOTAL SAMPLE 
n=425 
PAST SUICIDE ATTEMPT 
n=62 (14.6%) 
NO SUICIDE ATTEMPT 
n=363 (85.2%) 
GENDER (M:F) 180 (42%):245 (58%) 25(40%):37(60%) 155(43%):208(57%) 
MEAN AGE ± SD (years) 42.9 ± 12.6 43±11.8 42.9±12.8 
MEAN YBOCS SCORE ± 
SD 
21.7 ± 7.9 23.2±8.3 21.5±7.8 
MEAN AGE AT ONSET 
± SD 
19.2±9.9 17.9±9.7 19.4±10 
ADULT ONSET 
 
182 (42.8%) 21 (33.9%) 161 (44.4%) 
PRE-ADULT ONSET 243 (57.2%) 41 (66.1%) 202 (55.6%) 
HIGH SEVERITY OF 
ILLNESS (YBOCS24) 
(Y:N) 
172(43%):228(57%) 29(50%):29(50%) 143(42%):199(58%) 
PSYCHIATRIC 
COMORBIDITY 
(Y:N) 
100(23%):325(76%) 37(60%):25(40%)** 63(17%):300(83%) 
PSYCHIATRIC POLY-
COMORBIDITY (Y:N) 
20(5%):405(95%) 5(8%):57(92%) 15(4%):348(96%) 
PSYCHIATRIC 
THERAPY (Y:N) 
293(88%):38(12%) 29(81%):7(19%) 264(90%):31(10%) 
CBT (Y:N) 174(42%):240(58%) 40(66%):21(34%)** 134(38%):219(62%) 
LIFETIME 
PSYCHIATRIC 
HOSPITALIZATIONS 
(Y:N) 
75(18%):340(82%) 37(62%):23(38%)** 38(11%):317(89%) 
MEDICAL 
COMORBIDITY (Y:N) 
81(20%):323(80%) 31(51%):30(49%)** 50(15%):293(85%) 
GEOGRAPHICAL 
AREA 
EUROPE 172 (42.5%) 
AMERICA 70 (17.3%) 
SOUTH AFRICA 95 
(23.5%)* 
MIDDLE EAST 68 (16.8%) 
EUROPE 25 (40%)** 
AMERICA 8 (13%) 
SOUTH AFRICA 24 
(39%)** 
MIDDLE EAST 5(8%) 
EUROPE 147 (42.9%) 
AMERICA 62 (18.1%) 
SOUTH AFRICA 71 
(20.7%)* 
MIDDLE EAST 63(18.4%) 
 
Values for categorical and continuous variables are expressed as N (%) and mean ± SD, respectively. Reported variables had a 
percentage of missing data ranging from 0% to 22%.  
Statistics:  
*: p<.05; ** p<.001 
Legend: Y-BOCS: Yale-Brown Obsessive Compulsive Scale; CBT: Cognitive behavioral therapy 
Figure 1. Presence of psychiatric and medical comorbidities and hospitalizations in subgroups of 
OCD patients with and without positive lifetime history of suicide attempt, expressed in percentage  
 
 
Statistics 
**: p<.001 
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